Chlordiazepoxide Hydrochloride And Clidinium Bromide
NDC Package 70700-185-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Chlordiazepoxide Hydrochloride And Clidinium Bromide is capsules is indicated to control emotional and somatic factors in gastrointestinal disorders. Marketed by Xiromed, Llc, this product is identified by NDC 70700-185 and is authorized under FDA application ANDA210579.

Identification & Billing

NDC Package Code
70700-185-01
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
70700-185
11-Digit Billing Format
70700018501
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 889614 - chlordiazePOXIDE HCl 5 MG / clidinium bromide 2.5 MG Oral Capsule
  • RxCUI: 889614 - chlordiazepoxide hydrochloride 5 MG / clidinium bromide 2.5 MG Oral Capsule

Clinical Specifications

Proprietary Name
Chlordiazepoxide Hydrochloride And Clidinium Bromide
Dosage Form
-
Usage Information
Chlordiazepoxide hydrochloride and clidinium bromide capsules is indicated to control emotional and somatic factors in gastrointestinal disorders. Chlordiazepoxide hydrochloride and clidinium bromide capsules may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.

Regulatory & Marketing

Labeler Name
Xiromed, Llc
FDA Application #
ANDA210579
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-05-2021
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70700-185-01 identifies a specific commercial package of 100 capsule in 1 bottle of Chlordiazepoxide Hydrochloride And Clidinium Bromide, labeled by Xiromed, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Xiromed, Llc on April 05, 2021. The current certification is valid through December 31, 2024.

How is this Xiromed, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70700018501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70700-185-01
11-Digit CMS (5-4-2)
70700-0185-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.